Erythropoietin use in cancer patients: a matter of life and death?

Editorial

David P Steensma et al. J Clin Oncol. 2005.

. 2005 Sep 1;23(25):5865-8.

doi: 10.1200/JCO.2005.05.036. Epub 2005 Aug 8.

No abstract available

Comment in

Erythropoietin: high profile, high scrutiny.
Crawford J. Crawford J. J Clin Oncol. 2007 Mar 20;25(9):1021-3. doi: 10.1200/JCO.2006.08.8153. Epub 2007 Feb 20. J Clin Oncol. 2007. PMID: 17312331 No abstract available.

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.
Leyland-Jones B, Semiglazov V, Pawlicki M, Pienkowski T, Tjulandin S, Manikhas G, Makhson A, Roth A, Dodwell D, Baselga J, Biakhov M, Valuckas K, Voznyi E, Liu X, Vercammen E. Leyland-Jones B, et al. J Clin Oncol. 2005 Sep 1;23(25):5960-72. doi: 10.1200/JCO.2005.06.150. Epub 2005 Aug 8. J Clin Oncol. 2005. PMID: 16087945 Clinical Trial.